相似文献
1
Drug-targeting by monoclonal antibodies.
Br J Cancer. 1987 Mar;55(3):227-31. doi: 10.1038/bjc.1987.44.
2
New research and treatment options for acute myeloid leukemia.
Am J Manag Care. 2000 Oct;6(18 Suppl):S973-4.
3
Immunotoxin therapy of malignancy.
Important Adv Oncol. 1992:111-35.
4
Drug targeting with monoclonal antibodies. A review.
Acta Oncol. 1992;31(1):91-7. doi: 10.3109/02841869209088274.
5
Overview of acute myeloid leukemia.
Am J Manag Care. 2000 Oct;6(18 Suppl):S971-2.
6
Monoclonal antibodies and immunoconjugates for cancer treatment.
Cancer Chemother Biol Response Modif. 1988;10:397-415.
7
Monoclonal antibodies. Future potential in cancer chemotherapy.
Drugs. 1989 Nov;38(5):645-57. doi: 10.2165/00003495-198938050-00001.
8
Antibody-drug conjugates as targeted cancer therapeutics.
Yao Xue Xue Bao. 2009 Sep;44(9):943-52.
9
[Targeting therapy of cancer using monoclonal antibody-antitumor drug conjugate].
Nihon Rinsho. 1989 Jun;47(6):1391-5.
10
Serotherapy of cancer.
Semin Oncol. 1989 Jun;16(3):180-98.
引用本文的文献
1
Electro-Acupuncture Promotes Accumulation of Paclitaxel by Altering Tumor Microvasculature and Microenvironment in Breast Cancer of Mice.
Front Oncol. 2019 Jul 2;9:576. doi: 10.3389/fonc.2019.00576. eCollection 2019.
2
Antibody mediated targeting of radioisotopes, drugs and toxins in diagnosis and treatment.
Indian J Pediatr. 1990 Jan-Feb;57(1):29-46. doi: 10.1007/BF02722127.
3
Systemic immunotoxin therapy of cancer: advances and prospects.
Br J Cancer. 1991 Oct;64(4):624-30. doi: 10.1038/bjc.1991.374.
4
Comparative pharmacokinetic properties of murine monoclonal antibody A7 modified with neocarzinostatin, dextran and polyethylene glycol.
Jpn J Cancer Res. 1991 Oct;82(10):1145-50. doi: 10.1111/j.1349-7006.1991.tb01769.x.
本文引用的文献
1
Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody.
Cancer Res. 1980 Mar;40(3):717-21.
2
Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells.
Exp Cell Res. 1980 Apr;126(2):321-6. doi: 10.1016/0014-4827(80)90270-0.
3
The preparation and cytotoxic properties of antibody-toxin conjugates.
Immunol Rev. 1982;62:119-58. doi: 10.1111/j.1600-065x.1982.tb00392.x.
4
Serotherapy of acute lymphoblastic leukemia with monoclonal antibody.
Blood. 1981 Jul;58(1):141-52.
5
Kinetics of cytotoxicity induced by immunotoxins. Enhancement by lysosomotropic amines and carboxylic ionophores.
J Biol Chem. 1984 Aug 10;259(15):9359-64.
6
Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain.
J Exp Med. 1984 Jul 1;160(1):341-6. doi: 10.1084/jem.160.1.341.
7
Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?
Proc Natl Acad Sci U S A. 1984 Jan;81(1):216-9. doi: 10.1073/pnas.81.1.216.
8
Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells.
Proc Natl Acad Sci U S A. 1983 Oct;80(20):6332-5. doi: 10.1073/pnas.80.20.6332.
9
Tumor therapy with monoclonal antibodies.
Fed Proc. 1983 Jun;42(9):2650-6.
10
Efficient generation in vitro, from human peripheral blood cells, of monoclonal Epstein-Barr virus transformants producing specific antibody to a variety of antigens without prior deliberate immunization.
Proc Natl Acad Sci U S A. 1983 Jul;80(14):4484-8. doi: 10.1073/pnas.80.14.4484.
Zotero 插件